Skip to content

DENTAL-LAB

Active
Private limited companyfounded 200323 yrs activeTurnhoutsebaan 339, 2110 Wijnegem, BelgiumKBO/BCE: BE 0859.792.558

DENTAL-LAB has been active since 2003 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €229k and a net result of €22k. Equity is growing by ~9.1% per year across the filed fiscal years. Its solvency ranks better than 92% of 839 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.3% (very low).

Checked score

Score 2024
94 / 100
Excellent= vs 2023
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability48▲+9
Solvency100=
Growth52=
Stability100
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €22k at 30 days acceptable
Liquidity ample (current ratio 9.68 against 5.37 in 2023), and 8.4% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Four signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 32
Relative position
BE, all sectors
reference
Sector 32
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 23 years 0 30 y
raises risk · Filed more than 90 days late
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 31-12-2025, 153 days past the deadline. Measured on financial year 2023: companies more than 90 days late are in an abnormal legal state today in 5.61% of cases, against 1.66% across all filers.
NBB · 10 filings
Deviation from the deadline
2025
not confirmed
2024
153 d late
2023
89 d late
2022
358 d late
2021
61 d late
2020
121 d late
2019
153 d late
← before the deadline after the deadline →
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2024, micro schema

Equity
€229k▲ 10.5%
2023 · €207k
2018: €128k 2019: €147k 2020: €160k 2021: €176k 2022: €191k 2023: €207k
2018 → 2024
Total assets
€250k▼ 0.8%
2023 · €252k
2018: €204k 2019: €224k 2020: €194k 2021: €202k 2022: €235k 2023: €252k
2018 → 2024
Net result
€22k▲ 33.7%
2023 · €16k
2018: €33k 2019: €29k 2020: €13k 2021: €17k 2022: €15k 2023: €16k
2018 → 2024
Working capital
€183k▼ 6.5%
2023 · €196k
2018: €126k 2019: €162k 2020: €133k 2021: €159k 2022: €177k 2023: €196k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20202021202220232024Trend
Equity€160k-€176k▲ 10.4%€191k▲ 8.3%€207k▲ 8.5%€229k▲ 10.5%
Operating result€19k-€27k▲ 46.7%€20k▼ 27.4%€21k▲ 4.0%€32k▲ 58.3%
Net result€13k-€17k▲ 30.3%€15k▼ 11.6%€16k▲ 10.9%€22k▲ 33.7%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€10k€20k€30kOperating result 2020: €19k€19kNet result 2020: €13k€13kOperating result 2021: €27k€27kNet result 2021: €17k€17kOperating result 2022: €20k€20kNet result 2022: €15k€15kOperating result 2023: €21k€21kNet result 2023: €16k€16kOperating result 2024: €32k€32kNet result 2024: €22k€22k20202021202220232024
After the dip in 2022 the operating result has climbed two years in a row; 2024 is 58% above 2023 and is the highest year so far.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €250k
Fixed assets €46k▲ 296%
Current assets €204k▼ 15.1%
Equity and liabilities €250k
Equity €229k▲ 10.5%
Debt €21k▼ 52.9%
The debt ratio falls from 17.8% to 8.4%: equity grows while debt is paid down.
Key figures and ratios
2024 value · change against 2023
EBITDA
€38k
2023 · €26k
Cash flow
€27k
2023 · €22k
Solvency
91.6%
2023 · 82.2%
Current ratio
9.68
2023 · 5.37
Quick ratio
8.59
2023 · 4.68
Debt / equity
0.09
2023 · 0.22
ROE
9.5%
2023 · 7.9%
ROA
8.7%
2023 · 6.5%
Interest coverage
61.58
2023 · 53.88
Debt
€21k
2023 · €45k
Debt ≤ 1 year
€21k
2023 · €45k
Income taxes
€10k
2023 · €4k
Staff costs
€18k
2023 · €46k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet Code20232024
Assets
Total assets20/58€252k€250k
Fixed assets21/28€12k€46k
Tangible fixed assets22/27€12k€46k
Plant, machinery and equipment23€8k€4k
Furniture and vehicles24-€39k
Other tangible fixed assets26€4k€2k
Current assets29/58€240k€204k
Stocks and contracts in progress3€31k€23k
Stocks30/36€31k€23k
Amounts receivable within one year40/41€64k€69k
Trade receivables40€55k€60k
Other amounts receivable41€9k€9k
Cash at bank and in hand54/58€145k€110k
Deferred charges and accrued income490/1€892€2k
Equity and liabilities
Total equity and liabilities10/49€252k€250k
Equity10/15€207k€229k
Contributions10/11€67k€67k=
Reserves13€140k€162k
Non-distributable reserves130/1€7k€7k=
Reserves not available under the articles1311€7k€7k=
Distributable reserves133€134k€155k
Amounts payable17/49€45k€21k
Amounts payable within one year42/48€45k€21k
Current portion of amounts payable after more than one year42€3k-
Trade debts44€11k-
Suppliers440/4€11k-
Advances received on contracts in progress46€8k€2k
Taxes, remuneration and social security45€6k€2k
Taxes450/3-€2k
Remuneration and social security454/9€6k-
Other amounts payable47/48€16k€17k
Income statement Code20232024
Remuneration, social security and pensions62€46k€18k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€5k€5k
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€-10k
Other operating charges640/8€3k€13k
Gross operating margin9900€74k€58k
Operating profit (loss)9901€21k€32k
Financial income75/76B-€15
Recurring financial income75-€15
Financial charges65/66B€480€610
Recurring financial charges65€480€610
Profit (loss) for the period before taxes9903€20k€32k
Income taxes67/77€4k€10k
Profit (loss) for the period9904€16k€22k
Profit (loss) for the period to be appropriated9905€16k€22k
Appropriation of the result
Profit (loss) to be appropriated9906€16k€22k
Transfer to equity691/2€16k€22k
To other reserves6921€16k€22k

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

2025
31-12
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 153 days late
2024
28-10
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 89 days late
23-07
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 358 days late
2023
31-12
Financial Equity above €200kEq €207k ▲8.5%
6 profitable years in a row build equity to €207k.
2022
30-09
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 61 days late
2021
29-11
NBB filing Annual accounts filed
fiscal year 2020 · micro schema · 121 days late
2020
31-12
Financial Weakest financial yearnet €13k ▼55.5%
Net result drops to €13k, the lowest in the series; recovery starts the following year.
31-12
Financial Equity above €150kEq €160k ▲8.7%
3 profitable years in a row build equity to €160k.
31-12
NBB filing Annual accounts filed
fiscal year 2019 · micro schema · 153 days late
2019
07-08
NBB filing Annual accounts filed
fiscal year 2018 · micro schema · 7 days late
2018
20-08
NBB filing Annual accounts filed
fiscal year 2017 · micro schema · 20 days late
2017
27-06
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
2016
16-06
NBB filing Annual accounts filed
fiscal year 2015 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Wijnegem · 1 establishment unit since 2003
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Turnhoutsebaan 3392110 Wijnegem
Ground area
699 m²
Building footprint
628 m²
Volume, LiDAR
4,594 m³
Parcel 11050B0133/00G000, Flanders · tallest building 17.2 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
DENTAL-LAB
Turnhoutsebaan 339, 2110 WijnegemNACE 33103
since 20032.133.060.583
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
11050B0133/00G000 Flanders 699 m² 1 · 628 m² 17.2 m · 1 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 1,244 companies in sector 32500 we hold annual accounts for 691. 534 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded28-07-2003
Fiscal year end31-12
Activities, NACEBEL
32500Manufacture of medical and dental instruments and supplies
33103
Sources
Crossroads Bank for EnterprisesNational Bank · 21 filingsAddress and cadastre registers

Data from official sources, last processed on 15-09-2026. Scores and ratios are computed by Checked and are not a credit decision.